AAAAAA

   
Results: 1-21 |
Results: 21
Nocardia nova infection in a HIV-positive man
Authors: Jenney, AWJ McLean, CA Wesselingh, SL
Citation: Awj. Jenney et al., Nocardia nova infection in a HIV-positive man, INT J STD A, 12(5), 2001, pp. 348-349
Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice
Authors: Cherny, RA Atwood, CS Xilinas, ME Gray, DN Jones, WD McLean, CA Barnham, KJ Volitakis, I Fraser, FW Kim, YS Huang, XD Goldstein, LE Moir, RD Lim, JT Beyreuther, K Zheng, H Tanzi, RE Masters, CL Bush, AI
Citation: Ra. Cherny et al., Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice, NEURON, 30(3), 2001, pp. 665-676
Variable phenotype of Alzheimer's disease with spastic paraparesis
Authors: Smith, MJ Kwok, JBJ McLean, CA Kril, JJ Broe, GA Nicholson, GA Cappai, R Hallupp, M Cotton, RGH Masters, CL Schofield, PR Brooks, WS
Citation: Mj. Smith et al., Variable phenotype of Alzheimer's disease with spastic paraparesis, ANN NEUROL, 49(1), 2001, pp. 125-129
Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid
Authors: Fodero, LR Saez-Valero, J Barquero, MS Marcos, A McLean, CA Small, DH
Citation: Lr. Fodero et al., Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid, J NEUROCHEM, 79(5), 2001, pp. 1022-1026
The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease
Authors: Campbell, BCV McLean, CA Culvenor, JG Gai, WP Blumbergs, PC Jakala, P Beyreuther, K Masters, CL Li, QX
Citation: Bcv. Campbell et al., The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease, J NEUROCHEM, 76(1), 2001, pp. 87-96
Effect of femoral component designs on the contact and tracking characteristics of the unresurfaced patella in total knee arthroplasty
Authors: Tanzer, M McLean, CA Laxer, E Casey, J Ahmed, AM
Citation: M. Tanzer et al., Effect of femoral component designs on the contact and tracking characteristics of the unresurfaced patella in total knee arthroplasty, CAN J SURG, 44(2), 2001, pp. 127-133
Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease
Authors: Cherny, RA Barnham, KJ Lynch, T Volitakis, I Li, QX McLean, CA Multhaup, G Beyreuher, K Tanzi, RE Masters, CL Bush, AI
Citation: Ra. Cherny et al., Chelation and intercalation: Complementary properties in a compound for the treatment of Alzheimer's disease, J STRUCT B, 130(2-3), 2000, pp. 209-216
Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies
Authors: Campbell, BCV Li, QX Culvenor, JG Jakala, P Cappai, R Beyreuther, K Masters, CL McLean, CA
Citation: Bcv. Campbell et al., Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies, NEUROBIOL D, 7(3), 2000, pp. 192-200
Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease
Authors: Collins, S Boyd, A Fletcher, A Gonzales, MF McLean, CA Masters, CL
Citation: S. Collins et al., Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease, J CL NEUROS, 7(3), 2000, pp. 195-202
Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid
Authors: Collins, S Boyd, A Fletcher, A Gonzales, M McLean, CA Byron, K Masters, CL
Citation: S. Collins et al., Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid, J CL NEUROS, 7(3), 2000, pp. 203-208
Ischemic heart disease in black South African stroke patients
Authors: Joubert, J McLean, CA Reid, CM Davel, D Pilloy, W Delport, R Steyn, L Walker, ARP
Citation: J. Joubert et al., Ischemic heart disease in black South African stroke patients, STROKE, 31(6), 2000, pp. 1294-1298
Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease
Authors: Saez-Valero, J Barquero, MS Marcos, A McLean, CA Small, DH
Citation: J. Saez-valero et al., Altered glycosylation of acetylcholinesterase in lumbar cerebrospinal fluid of patients with Alzheimer's disease, J NE NE PSY, 69(5), 2000, pp. 664-667
Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease
Authors: Collins, S Boyd, A Fletcher, A Byron, K Harper, C McLean, CA Masters, CL
Citation: S. Collins et al., Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease, ARCH NEUROL, 57(7), 2000, pp. 1058-1063
The role of NAC in amyloidogenesis in Alzheimer's disease - Author's reply
Authors: Culvenor, JG McLean, CA Campbell, BCV Masters, CL Li, QX Jakala, P Hartmann, T Beyreuther, K
Citation: Jg. Culvenor et al., The role of NAC in amyloidogenesis in Alzheimer's disease - Author's reply, AM J PATH, 156(2), 2000, pp. 735-736
Early-onset Alzheimer's disease caused by a novel mutation at codon 219 ofthe presenilin-1 gene
Authors: Smith, MJ Gardner, RJM Knight, MA Forrest, SM Beyreuther, K Storey, E McLean, CA Cotton, RGH Cappal, R Masters, CL
Citation: Mj. Smith et al., Early-onset Alzheimer's disease caused by a novel mutation at codon 219 ofthe presenilin-1 gene, NEUROREPORT, 10(3), 1999, pp. 503-507
Soluble pool of A beta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease
Authors: McLean, CA Cherny, RA Fraser, FW Fuller, SJ Smith, MJ Beyreuther, K Bush, AI Masters, CL
Citation: Ca. Mclean et al., Soluble pool of A beta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, ANN NEUROL, 46(6), 1999, pp. 860-866
Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?
Authors: Small, DH McLean, CA
Citation: Dh. Small et Ca. Mclean, Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?, J NEUROCHEM, 73(2), 1999, pp. 443-449
Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice
Authors: Li, QX Maynard, C Cappai, R McLean, CA Cherny, RA Lynch, T Culvenor, JG Trevaskis, J Tanner, JE Bailey, KA Czech, C Bush, AI Beyreuther, K Masters, CL
Citation: Qx. Li et al., Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice, J NEUROCHEM, 72(6), 1999, pp. 2479-2487
Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease
Authors: Saez-Valero, J Sberna, G McLean, CA Small, DH
Citation: J. Saez-valero et al., Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease, J NEUROCHEM, 72(4), 1999, pp. 1600-1608
Aqueous dissolution of Alzheimer's disease A beta amyloid deposits by biometal depletion
Authors: Cherny, RA Legg, JT McLean, CA Fairlie, DP Huang, XD Atwood, CS Beyreuther, K Tanzi, RE Masters, CL Bush, AI
Citation: Ra. Cherny et al., Aqueous dissolution of Alzheimer's disease A beta amyloid deposits by biometal depletion, J BIOL CHEM, 274(33), 1999, pp. 23223-23228
Non-A beta component of Alzheimer's disease amyloid (NAC) revisited - NAC and alpha-synuclein are not associated with A beta amyloid
Authors: Culvenor, JG McLean, CA Cutt, S Campbell, BCV Maher, F Jakala, P Hartmann, T Beyreuther, K Masters, CL Li, QX
Citation: Jg. Culvenor et al., Non-A beta component of Alzheimer's disease amyloid (NAC) revisited - NAC and alpha-synuclein are not associated with A beta amyloid, AM J PATH, 155(4), 1999, pp. 1173-1181
Risultati: 1-21 |